Severe symptomatic hypocalcaemia following a single dose of denosumab

Med J Aust. 2013 Aug 19;199(4):242-3. doi: 10.5694/mja13.10038.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged, 80 and over
  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Bone Neoplasms / drug therapy*
  • Bone Neoplasms / secondary
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Denosumab
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Hypocalcemia / chemically induced*
  • Hypocalcemia / therapy
  • Risk Factors
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Denosumab